IP Library Granted Patent US 7,476,883
Granted Patent B2
US 7,476,883 · App. 11/441,999 · Granted Jan 13, 2009

Biomarker generator system

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,476,883
App. No.
11/441,999
Granted
Jan 13, 2009
Kind
B2
Abstract

A biomarker generator system for producing approximately one (1) unit dose of a biomarker. The biomarker generator system includes a small, low-power particle accelerator (“micro-accelerator”) and a radiochemical synthesis subsystem having at least one microreactor and/or microfluidic chip. The micro-accelerator is provided for producing approximately one (1) unit dose of a radioactive substance, such as a substance that emits positrons. The radiochemical synthesis subsystem is provided for receiving the radioactive substance, for receiving at least one reagent, and for synthesizing the approximately one (1) unit dose of a biomarker.

Claims (47)

1. A system for producing a radiochemical, said system comprising:

a particle accelerator for generating a beam of charged particles having a maximum beam power of less than, or equal to, approximately fifty (50) watts, the beam consisting essentially of particles having a minimum energy greater than, or equal to, five (5) MeV, and for directing the beam of charged particles along a path;

a target positioned in the path of the beam of charged particles, said target serving to receive a target substance having a composition selected for producing a radioactive substance during interaction with the beam of charged particles; and

a radiochemical synthesis subsystem having at least one microreactor and/or microfluidic chip, said radiochemical synthesis subsystem for receiving the radioactive substance, for receiving at least one reagent, and for synthesizing the radiochemical.

2. The system of claim 1 , wherein the radioactive substance includes a positron-emitting radioactive isotope selected from the group consisting of carbon-11, nitrogen-13, oxygen-15, and fluorine-18.

3. The system of claim 1 , wherein the radioactive substance is a positron-emitting substance selected from the group consisting of [ 11 C]CH 4 , [ 11 C]CO 2 , [ 11 C]CH 3 I, [ 13 N]N 2 , [ 15 O]O 2 , [ 18 F]F − , and [ 18 F]F 2 .

4. A system for producing a radiochemical, said system comprising:

a cyclotron for generating a beam of charged particles having a maximum beam power of less than, or equal to, approximately fifty (50) watts, a the beam consisting essentially of particles having a minimum energy greater than, or equal to, five (5) MeV , and for directing the beam of charged particles along a path;

a target positioned in the path of the beam of charged particles, said target serving to receive a target substance having a composition selected for producing a radioactive substance during interaction with the beam of charged particles; and

a radiochemical synthesis subsystem having at least one microreactor and/or microfluidic chip, said radiochemical synthesis subsystem for receiving the radioactive substance, for receiving at least one reagent, and for synthesizing the radiochemical.

5. The system of claim 1 , wherein said particle accelerator includes an internal target subsystem.

6. The system of claim 4 , wherein said cyclotron includes an internal target subsystem.

7. The system of claim 1 wherein said particle accelerator includes a permanent magnet for directing the beam as the beam is being accelerated.

8. The system of claim 4 , wherein said particle accelerator includes a permanent magnet for directing the beam as the beam is being accelerated.

9. The system of claim 1 , wherein the beam consists essentially of protons having an energy of approximately seven (7) MeV.

10. The system of claim 9 , wherein said particle accelerator is a cyclotron.

11. The system of claim 1 , wherein the radioactive substance includes a radioisotope that emits positrons.

12. The system of claim 11 , wherein the radioisotope that emits positrons is a PET biomarker .

13. The system of claim 12 , wherein said radiochemical synthesis subsystem is for synthesizing per run a maximum of approximately one (1) unit dose of the PET biomarker.

14. The system of claim 13 , wherein the approximately one (1) unit dose of the PET biomarker has a maximum activity of less than, or equal to, approximately twenty (20) mCi.

15. A system for producing a radiochemical, said system comprising:

a particle accelerator for producing per run a radioactive substance having a maximum activity of less than, or equal to, approximately sixty (60) mCi; and

a radiochemical synthesis subsystem having at least one microreactor and/or microfluidic chip, said radiochemical synthesis subsystem for receiving the radioactive substance, for receiving at least one reagent, and for synthesizing the radiochemical.

16. The system of claim 15 , wherein the radioactive substance includes a positron-emitting radioisotope selected from the group consisting of carbon-11, nitrogen-13, oxygen-15, and fluorine-18.

17. The system of claim 15 , wherein the radioactive substance is a positron-emitting substance selected from the group consisting of [ 11 C]CH 4 , [ 11 C]CO 2 , [ 11 C]CH 3 I, [ 13 N]N 2 , [ 15 O]O 2 , [ 18 F]F − , and [ 18 F]F 2 .

18. The system of claim 15 , wherein said particle accelerator is for generating a beam of charged particles having a maximum beam power of less than, or equal to, approximately fifty (50) watts, the beam consisting essentially of particles having a minimum energy greater than, or equal to, five (5) MeV.

19. The system of claim 18 , wherein the beam consists essentially of protons having an energy of approximately seven (7) MeV.

20. The system of claim 15 , wherein said particle accelerator is a cyclotron.

21. The system of claim 18 , wherein said particle accelerator is a cyclotron.

22. The system of claim 15 , wherein said particle accelerator includes an internal target subsystem.

23. The system of claim 20 , wherein said cyclotron includes an internal target subsystem.

24. The system of claim 21 , wherein said cyclotron includes an internal target subsystem.

25. The system of claim 15 , wherein said particle accelerator includes a permanent magnet for directing the beam.

26. The system of claim 20 , wherein said particle accelerator includes a permanent magnet for directing the beam.

27. The system of claim 15 , wherein said radiochemical synthesis subsystem is for processing per run a maximum of less than, or equal to, approximately sixty (60) mCi of the radioactive substance.

28. The system of claim 27 , wherein the radioactive substance includes a radioisotope that emits positrons.

29. The system of claim 28 , wherein the radioisotope that emits positrons is a PET biomarker.

30. The system of claim 29 , wherein said radiochemical synthesis subsystem is for synthesizing per run a maximum of approximately one (1) unit dose of the PET biomarker.

31. The system of claim 30 , wherein the approximately one (1) unit dose of the PET biomarker has a maximum activity of less than, or equal to, approximately twenty (20) mCi.

32. A method for the producing approximately one (1) unit dose of a PET biomarker, said method comprising the steps of:

(a) providing a particle accelerator for generating a beam of charged particles having a maximum beam power of less than, or equal to, approximately fifty (50) watts, the beam consisting essentially of particles having a minimum energy greater than, or equal to, five (5) MeV, said particle accelerator being incapable of generating a beam of charged particles having a beam power in excess of approximately fifty (50) watts;

(b) generating a beam of charged particles using said particle accelerator;

(c) bombarding a substance with the beam of charged particles such as to produce a radioactive substance;

(d) providing a radiochemical synthesis subsystem having at least one microreactor and/or microfluidic chip, said radiochemical synthesis subsystem for receiving the radioactive substance, for receiving at least one reagent, and for synthesizing the approximately one (1) unit dose of a PET biomarker;

(e) transferring the radioactive substance to said radiochemical synthesis subsystem;

(f) transferring at least one reagent to said radiochemical synthesis subsystem; and

(g) synthesizing the approximately one (1) unit dose of a PET biomarker, using said radiochemical synthesis subsystem.

Assignments (7)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Feb 14, 2019
From: BEST ABT INC.
To: SWK FUNDING LLC
Reel/Frame 048351/0263 →
CHANGE OF NAME Recorded Nov 19, 2018
From: ADVANCED BIOMARKER TECHNOLOGIES, LLC
To: ABT MOLECULAR IMAGING, INC.
Reel/Frame 047546/0909 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2018
From: ABT MOLECULAR IMAGING, INC.
To: BEST ABT, INC.
Reel/Frame 047511/0829 →
SECURITY INTEREST Recorded Dec 31, 2015
From: ABT MOLECULAR IMAGING, INC.
To: PACIFIC WESTERN BANK
Reel/Frame 037391/0210 →
RELEASE OF SECURITY INTEREST Recorded Nov 3, 2014
From: SQUARE 1 BANK
To: ABT MOLECULAR IMAGING, INC.
Reel/Frame 034090/0551 →
SECURITY INTEREST Recorded Mar 18, 2014
From: ABT MOLECULAR IMAGING, INC.
To: SQUARE 1 BANK
Reel/Frame 032464/0298 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 26, 2006
From: NUTT, RONALD
To: ADVANCED BIOMARKER TECHNOLOGIES, LLC
Reel/Frame 017944/0136 →